Patent · US Active

Activity levels for diffusing alpha-emitter radiation therapy

US12070620B2 · kind B2 · utility

0Cited by

9References

4Claims

0Family size

Assignee

Alpha Tau Medical Ltd. · IL

Inventors

Itzhak Kelson · Tel Aviv-Yafo, IL
Yona Keisari · Ramat Gan, IL
Amnon Gat · Matan, IL
Robert Den · Cynwyd Estates, US
Ofer Magen · Hod HaSharon, IL
Vered Domankevich · Hod HaSharon, IL
Lior Arazi · Tel Aviv-Yafo, IL
Tomer Cooks · Gdera, IL
Guy Heger · Ramat Gan, IL
Mirta Duman{hacek over (c)}ić · Beer Sheva, IL
Ishai Luz · Gevim, IL
Maayan Hedva Vatarescu · al-Araqeeb, IL

Key dates

Filing date	Jan 9, 2023
Grant date	Aug 27, 2024
Priority date	—
Expiry date	Jan 9, 2043

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61N2005/1087
WIPO fieldMedical technology
WIPO sectorInstruments

Abstract

A method for treating a cancerous tumor, by implanting in the cancerous tumor at least one diffusing alpha-emitter radiation therapy (DaRT) source (21) with a suitable radon release rate and for a given duration, such that the source (21) provides during the given duration a cumulated activity of released radon of at least 10 Mega becquerel (MBq) hour, per centimeter length. Optionally, the sources (21) are implanted in an array (160) of sources (21), each source separated from its neighboring sources (21) in the array by not more than 4.5 millimeters.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.